Aknamed, a cloud-based healthcare provide chain platform in India, has been bought by digital pharmacy PharmEasy. It largely acquired shares from the corporate price between $180-$190 million, in accordance with Financial Occasions.
WHAT THEY DO
Launched in 2015, PharmEasy operates an internet and cell app-based platform the place clients can order medicines, buy healthcare merchandise and ebook diagnostic assessments.
However, Aknamed, which began in 2018, supplies a provide chain platform that permits hospitals to simplify, optimise and monitor procurement and consumption utilizing cloud-based know-how.
WHY IT MATTERS
Based mostly on a information report, the acquisition is a part of PharmEasy’s plan to diversify its companies from being an internet medication supply platform to turning into a largely on-line healthcare agency.
THE LARGER CONTEXT
Aknamed’s acquisition follows PharmEasy’s buy of listed diagnostics agency Thyrocare in June. It additionally comes forward of its reported submitting of draft IPO papers by subsequent month. This week, the identical media publication reported that the corporate is finalising a $200 million funding spherical participated by US-based and Southeast Asian traders which may doubtlessly increase its worth to $6 billion from $4.2 billion as of June.
In the meantime, Aknamed acquired pharmaceutical merchandise distributor Vardhman Well being Specialties for $35 million in Might.